Clinical trial
Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C
NCT01821625 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- April 30, 2013
- Completion date
- April 30, 2016
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.